江湖电竞买外围
WEED
CA
0.11
2.45%
Closed
$ 4.60
| Previous Close |
|---|
| $4.49 |
Volume: 1.78M
65 Day Avg: 2.62M
4.40
Day Range
4.60
2.79
52 Week Range
20.20
Overview
WEED Overview
Key Data
- Open $4.40
- Day Range 4.40 - 4.60
- 52 Week Range 2.79 - 20.20
- Market Cap $2.16B
- Shares Outstanding 479.98M
- Public Float 307.7M
- Beta N/A
- Rev. per Employee $156.85K
- P/E Ratio N/A
- EPS -$6.99
- Yield N/A
- Dividend N/A
- Ex-Dividend Date N/A
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 2.62M
Performance
| 5 Day |
|
| 1 Month |
|
| 3 Month |
|
| YTD |
|
| 1 Year |
|
Analyst Ratings
Number of Ratings
17
Full Ratings
Recent News
Canopy Growth swings to big loss as revenue falls 19%
Canopy Growth Corp. shares fell 6% in premarket trades Friday after the company said it lost C$2.08 billion ($1.61 billion), or $5.23 a share in its fiscal first quarter, compared to a profit of C$392.42 million, or C$1.0...
Canopy Growth stock price target cut to C$2.90 from C$5.00 at Stifel Nicolaus
Canopy Growth shares fall after it agrees to convert debt into stock in deal with Constellation Brands
Canopy Growth Corp. fell 17% in premarket trades on Thursday after the company said it reached an agreement with Constellation Brands Inc. to convert about $198 million of convertible debt into stock. Constellation agree...
Stocks in play: Canopy Growth Corporation
Today announces its financial results for the first quarter ended June 30, 2022. Net revenue of $110 ...
on Baystreet.ca
Stocks in play: Canopy Growth Corporation
Announced the appointment of Christelle Gedeon, Ph.D., as the Company's new Chief Legal Officer. Canopy ...
on Baystreet.ca
Stocks in play: Canopy Growth Corporation
Announced it will release its financial results for the first quarter fiscal year 2023 ended June 30, ...
on Baystreet.ca
Stocks in play: Canopy Growth Corporation
Announced the continued expansion of its cannabis beverage portfolio and a brand campaign that drives ...
on Baystreet.ca
Top 5 Ways to Profit from a Potential THCV Boom
THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and even ...
on Baystreet.ca
Stocks in play: Canopy Growth Corporation
Announces its financial results for the fourth quarter ended March 31, 2022. Net revenue of $112 million ...
on Baystreet.ca
Stocks in play: Canopy Growth Corporation.
Today unveiled a line-up of new offerings across its premium brand portfolio – 7ACRES, Ace Valley, Deep ...
on Baystreet.ca
Stocks in play: Canopy Growth Corporation
And Lemurian, Inc., a California-based producer of high-quality cannabis extracts and pioneer of clean ...
on Baystreet.ca
Top Stocks that Could Benefit from a Study of THCV
THCV, or tetrahydrocannabivarin may have the potential to help with energy, focus/attention, and eve ...
on Baystreet.ca
Rare Cannabinoids Could be a Therapeutic Game-Changer for Unmet Needs
Cannabinoids, such as cannabidivarin (CBDV) could be a therapeutic game-changer. In fact, according ...
on Baystreet.ca
This is Why Investors Are Excited About the Potential of Rare Cannabinoids
Cannabinoids, such as cannabidivarin (CBDV) may be rare, but may also have exciting potential. In fact, ...
on Baystreet.ca
The U.S. is One Step Closer to Cannabis Legalization at the Federal Level
Over the last few weeks, the U.S. House passed a bill that could pave the way for legalizing cannabis ...
on Baystreet.ca
Demand for Cannabinol (CBN) Could Create a Massive Opportunity
At the moment, CBN, or cannabinol is soaring in popularity. That could be significant news for companies, ...
on Baystreet.ca
Stocks in play: Canopy Growth Corporation
Is unveiling its 7ACRES Know the Grow content series, providing Canadians with an inside look at the ...
on Baystreet.ca
Curaleaf, Canopy Growth, Green Thumb: Which Cannabis Stock is a Better Pick?
Optimism over cannabis legalization at the federal level in the U.S. has again triggered interest in marijuana stocks. Several cannabis stocks have plunged over the past 12 months due to the lack of movement toward federal...
on TipRanks.com
Stocks in play: Canopy Growth Corporation
Said its scientific research team has announced positive results from a six-month, randomized clinical ...
on Baystreet.ca
Medical Cannabis Company Akanda Up 163% in IPO Debut
Halo Collective Inc. (NEO: HALO) (OTCQB: HCANF), which holds a 44% stake in Akanda Corp. is benefiting ...
on Baystreet.ca
Medical Cannabis IPO Akanda Corp. Soared 265% on Debut
Akanda Corp. (NASDAQ: AKAN), an international medical cannabis company, commenced trading on The Nasdaq ...
on Baystreet.ca
Canopy Growth Corp.
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Competitors
| Name | Chg % | Market Cap |
|---|---|---|
| Burcon NutraScience Corp. |
|
$65.24M |
| Cipher Pharmaceuticals Inc. |
|
$70.77M |
| IBEX Technologies Inc. |
|
$13.4M |